News & Events

• September 16, 2020
  

  New Uses for Existing Drugs: Applications for COVID-19 and Valley Fever

  What is drug repurposing and why is it important? Learn more about the CURE ID web-based app made possible by the National Center for Advancing Translational Sciences (NCATS) and its utility for COVID-19 and Valley Fever. Health care professionals are encouraged to attend.

  Presenter: Marco Schito, PhD, C-Path Executive Director, Cure Drug Repurposing Collaboratory

  Part of Arizona Bioscience Week Educational Events | Register for AZBW 2020

• June 9, 2020
  

  Webinar: FDA Drug Topics: CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19

  This new webinar from the Center for Drug Evaluation (CDER), Division of Drug Information (DDI) is now available at:
  https://collaboration.fda.gov/p2aaislio098/

  The webinar is a demonstration of the CURE ID mobile app and web platform, developed by the U.S. Food and Drug Administration (FDA), in collaboration with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). CURE ID gives the global clinical community the opportunity to report novel uses of existing drugs for patients with difficult to treat infectious diseases, including COVID-19. C-Path’s CURE Drug Repurposing Collaboratory (CDRC) is working directly with the FDA and NCATS/NIH on this initiative.